Healthleap Raises $38M to Flag At-Risk Hospital Patients
Healthleap has raised $38 million in seed and Series A funding for an AI platform that reads patient records to identify hospital patients at risk of undiagnosed illness. The financing was detailed in reporting published on Oct. 7, 2026. TechCrunch
The financing breaks into two rounds. The $8 million seed round was co-led by Sequoia Capital and First Round Capital. The $30 million Series A was led by Hummingbird Ventures. Healthleap is not disclosing its valuation.
Healthleap was founded in South Africa in 2022 by siblings Jemima and Josiah Meyer. Josiah Meyer serves as chief executive and co-founder.
The platform plugs into a hospital's electronic health record system. It uses language models to pull information from written notes alongside structured data. The goal is to surface patients who may need a closer look from clinical staff.
Healthleap states its software does not diagnose patients. It only highlights items for additional review. In deployment, the system screens for malnutrition and delirium. It is now live in more than 50 hospitals for those two use cases.
The company grew from three hospital partners to more than 50 over the past year. Named customers include Penn Medicine, Cedars-Sinai, Intermountain, Houston Methodist and Emory Healthcare. Revenue grew more than 10x over the same period. TechCrunch
Healthleap sells three-year contracts priced according to a hospital's licensed bed count.
Looking at what this means for deployment, the design prioritizes fit over autonomy. The system lives inside the existing record system and works across both narrative notes and structured fields. It stops at flagging. For teams responsible for clinical informatics and operations, that combination is easier to absorb than a separate diagnostic tool. It leaves judgment with staff. It also keeps the initial scope narrow. Two conditions, one workflow, one integration point. That makes performance easier to monitor and easier to compare across sites.
In my view, the commercial structure is as telling as the technical one. Three-year terms priced by bed count give both sides a predictable basis for planning. Hospitals can estimate cost without metering every query. The vendor can focus on coverage and sustained use rather than per-click volume. If that use holds across more than 50 sites, expansion to additional conditions becomes a data and validation question rather than a new integration project. I have watched my own children adopt new tools without manuals, while hospitals adopt them only with proof. Healthleap is betting on the second path.
The long-arc benefit is practical. More patients get a second look who might otherwise be missed in a busy ward, and scarce specialist time goes where review suggests it is most needed. That is a modest claim, and for hospital software, modest claims that survive contact with daily workflow are the ones that last.
